Project Grant HT94252410218
Award Date
9/1/24
Completion Date
8/31/27
Dollars Obligated
$2.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, was awarded a $656,272 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research aimed at optimizing PD-1 immunotherapy through increased T cell regeneration and reduced antigen load. This 2-year project will be conducted in New York, NY from September 1, 2023 to August 31, 2025. The Military Medical...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $1,645,000.00 to The Trustees of Columbia University in the City of New York to research treating HER2 therapy-resistant brain metastasis using antidepressants. The award commenced on July 1, 2025 and is scheduled for completion on June 30, 2028. As a leading academic research institution, Columbia University will leverage its extensive expertise in...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,645,000 project grant to The Trustees of Columbia University in the City of New York to conduct research on "BONE FRACTURE-INDUCED JOINT BLEEDING AND POSTTRAUMATIC OSTEOARTHRITIS". The award period runs from May 1, 2025 to April 30, 2028. Columbia University, a leading academic research institution, will leverage its extensive expertise in biomedical research, public health, and...
This federal Project Grant award of $1,435,449.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) funds The Trustees of Columbia University in the City of New York to develop a wireless, implantable interface to the visual cortex. The objective is to transform health care for service members and the American public through innovative and impactful biomedical research focused on medical solutions for the battlefield. The grant period of...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $1,644,999 project grant to The Trustees of Columbia University in the City of New York to study the role of Streptococcus in esophageal neoplasia. The award, which runs from July 1, 2025 to June 30, 2028, will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The university's Health Sciences Division will...
The federal Project Grant award titled "PSYCHIATRIC ASPECTS OF POST-TRAUMATIC EPILEPSY" was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $650,000 award will fund biomedical research at The Trustees of Columbia University in the City of New York, Health Sciences Division over a 3-year period from Apr 2025 to Apr 2028. The research aims to investigate innovative medical solutions and transform healthcare for military...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,493,233 to The Trustees of Columbia University in the City of New York to fund research on gene therapy in a nonhuman primate model of cognitive defects in Parkinson's disease. The award commenced on November 15, 2024 and is set to be completed by November 14, 2027. The university's Health Sciences Division will leverage its...
This federal Project Grant award of $325,142, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports the development of a clinical-grade spinal cord neuroprosthesis to alleviate locomotor deficits in people with Parkinson's disease. The award, which has a performance period from September 1, 2025 to August 31, 2028, is being provided to Onward Medical Inc., a for-profit organization located in Boston, MA. The goal of this...
This federal Project Grant award of $1,316,000.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by The Trustees of Columbia University in the City of New York to advance Werner Syndrome Protein (WRN) as a promising therapeutic target for microsatellite instability-high (MSI-H) cancers. The award period runs from August 1, 2025 to July 31, 2029. This research aims to transform healthcare for military service...
This Project Grant award of $197,400.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the "Development of Patient-Derived CNS Metastasis Models with STK11 Inactivation for Drug Discovery" at The Trustees of Columbia University in the City of New York. This 1-year award, which commenced on February 15, 2025, will enable the university to conduct advanced biomedical research focused on innovative approaches to...